A new digital catalog for a new generation of life science, pre-clinical and bulk OEM/bioprocessing researchers. This new catalog highlights enzymes and related biochemicals for classical and molecular diagnostics, biochemistry, bioprocessing and pre-clinical research applications.
BioIVT, a leading provider of research models and services for drug and diagnostic development, has acquired Keystone Biologicals, Inc., a supplier of disease-state plasma, sera and controls, located in Hatboro, PA.
Samplla™, a family of specimen collection devices which are designed to provide ambient transportation for up to 21 days. Specimens applied to Samplla™ are immediately “dried and stabilized” within a local atmospheric condition using its Samplla Modified Atmosphere Packaging (sMAP), that provides an atmosphere separated from the ambient atmosphere and resistant to gas exchange – the result, stability. Samplla™ S device, the first product of this line of products was perfected to collect, transport and store bodily fluid specimens.
Randox Quality Control is set to introduce its brand new Acusera Infectious Disease (Serology) Controls at the American Association for Clinical Chemistry 2019.
The IFCC WORLDLAB SEOUL 2020 Organizing Committee is gearing up for an exciting and informative symposium programme including plenary lectures, educational workshops, satellite meetings and poster sessions. The Congress will cover all the scientific and technological aspects of Laboratory Medicine.
Sysmex America, Inc. announced the availability of its PS-10TM Sample Preparation System for use in flow cytometry. The highly automated and flexible PS-10, designed for complex laboratory tests and routine flow applications, provides clinical labs a new level of workflow efficiency and confidence in results.
Researchers have developed a novel test that identifies individuals who are the most likely to experience negative health effects if they eat a high salt diet. This new test and a second study showing that the ketogenic diet improves diabetes symptoms were presented today at the 71st AACC Annual Scientific Meeting & Clinical Lab Expo, and could empower people to transform their health through dietary changes.
A new study shows that a person taking the medicinal cannabis derivative cannabidiol (CBD) won’t fail a drug test for marijuana—but a person taking the emerging sleep aid cannabinol (CBN) will. These findings were presented today at the 71st AACC Annual Scientific Meeting & Clinical Lab Expo, and could prevent people from being unfairly penalized for using CBN.
A novel study has discovered metabolites that predict which Alzheimer’s patients are likely to see their symptoms improve with exercise therapy. These findings were unveiled today at the 71st AACC Annual Scientific Meeting & Clinical Lab Expo, and could be used to develop a blood test to guide Alzheimer’s treatment.
Research presented today at the 71st AACC Annual Scientific Meeting & Clinical Lab Expo shows that a questionnaire-based algorithm predicts the risk of a pregnant woman developing preeclampsia. This method could lower the high maternal death rate in resource-limited countries by identifying women who need treatment for this often fatal condition.
Groundbreaking research presented at the 71st AACC Annual Scientific Meeting & Clinical Lab Expo has revealed how transgender hormone therapy affects the results of common laboratory tests in the long term. This first-of-its-kind study could enable the development of transgender-specific reference intervals, which are crucial to ensuring that transgender patients get accurate diagnoses and equitable healthcare.
Pixcell’s HemoScreen™ is a portable cartridge-based platform. It is fast, simple to use, and a cost-effective means of providing crucial diagnostic information, near patient, where it is needed most.
Ins. For Renascence, a big data company focusing on insurance risk control, is committed to creating industry-level intelligence solutions, will exhibit their plans to attend the upcoming 71st American Association for Clinical Chemistry (AACC) Annual Scientific Meeting & Clinical Lab Expo in Anaheim, California from August 6-8. The company will use the time at the show to highlight its research developments.
The IFCC (International Federation of Clinical Chemistry and Laboratory Medicine) confers several Distinguished Awards to scientists and clinicians who work in clinical chemistry and laboratory medicine or related disciplines. Currently, calls for nominations are open for ten (10) IFCC Distinguished Awards for presentation at the IFCC Congress in May 2020, Seoul, Korea.
AACC released a position statement today calling for increased collaboration between clinical laboratories, the healthcare community, and federal agencies to end the opioid epidemic. The statement emphasizes that labs are critical to preventing opioid abuse and urges the medical community and government to leverage the expertise of clinical laboratory professionals to curb soaring drug overdoses in the U.S.
AACC released a position statement today calling for increased collaboration between clinical laboratories, the healthcare community, and federal agencies to end the opioid epidemic. The statement emphasizes that labs are critical to preventing opioid abuse and urges the medical community and government to leverage the expertise of clinical laboratory professionals to curb soaring drug overdoses in the U.S.
On August 4, a special session at the 71st AACC Annual Scientific Meeting & Clinical Lab Expo will shed much-needed light on the nuances of direct-to-consumer genetic testing.
At the 71st AACC Annual Scientific Meeting & Clinical Lab Expo, laboratory medicine experts will present the cutting-edge research and technology that is revolutionizing clinical testing and patient care. From August 4-8 in Anaheim, California, the meeting’s 200-plus sessions will deliver insights on a broad range of timely healthcare topics. Highlights of these include discussions exploring direct-to-consumer genetic testing, precision medicine’s progress to date, how genes shape the brain circuitry that defines human behavior, and emerging technologies ranging from new cannabis tests to extremely rapid molecular diagnostics.
Biotech companies have made remarkable strides developing lab-on-a-chip (LoaC) technology — ever smaller chips that integrate laboratory functions for rapid diagnostic testing. Performing the precise manufacturing steps that these remarkable diagnostic consumables require, such as the application of coating or the printing of barcodes, is getting more difficult and expensive as miniaturization progresses. SCHOTT now eases these challenges by offering NEXTERION® PreScora. These pre-scored substrates can undergo processing steps as a whole and easily be fashioned to their final size afterwards. This lowers production cost significantly while enabling diagnostic consumable and equipment manufacturers to leverage the performance advantages of a high quality glass chip.
A plethora of new products and upgrades are being showcased on booth 827, including:
• XL200 and XL640 – Our signature chemistry analysers now upgraded to include a touch screen with improved software for easier operation, longer walk-away time and faster TAT
• ELAN 30s– a new fully automated compact benchtop ELISA microstrip processor with easy to use software including QC reports and ability to perform 6 different tests simultaneously
• New Erba LIMS software with mobile app providing high function device interfacing and remote online approval of patient reports, eliminating need for expensive LIS systems.
ERBA Mannheim presenta en AACC 2019, NEXUS, la nueva generación en automatización para laboratorios.
• Nueva gama de instrumentos de química clínica, inmunoensayo y hematología, accesibles, modulares, integrados, con sistemas de selección y transporte de muestras, ofreciendo automatización poderosa y accesible para laboratorios en crecimiento.
• El Sistema de Hematología combina métodos tradicionales con Inteligencia Artificial e imágenes de ultra alta definición para analizar miles de celulas sanguíneas por minuto y así mejorar los tiempos de trabajo de su laboratorio.
• El Sistema de Inmunoensayo utiliza technología de Quimioluminiscencia de gran sensibilidad con un tecnología única en perlas magnéticas y un menu de más de 100 parámetros.
• El Sistema de Química Clínica cuenta con un modulo ISE de ultima generación y ofrece un Sistema innovador de manejo de reactivos para asegurar un incremento en el flujo y una mejora en la calidad de los resultados analíticos.
A new testing application for the biomarker Heart-Type Fatty Acid-Binding Protein (H-FABP) has been revealed by global diagnostics company Randox Laboratories.
Whilst H-FABP is most commonly recognized as an early biomarker of myocardial infarction, the assay’s clinical utility in cardiac surgery associated acute kidney injury (CSA-AKI) is notable.
The UNIVANTS of Healthcare Excellence Award annually recognizes interdisciplinary care teams who collaborate across disciplines and transform healthcare delivery, and ultimately patient lives. The programme’s goal is to inspire innovative solutions within healthcare that will positively affect patients, clinicians, payors, and health systems globally, to highlight best practices, inspire unity and to encourage novel, avant-garde ways of thinking, as the name UNIVANTS suggests
The new D 23 TC1® plasma separation media from I.W. Tremont delivers high yield, optically clear plasma from whole blood. Ideal for applications used in diagnostic devices where rapid conversion is required from small sample volumes (5-20 µl).
Stephen Young, PhD, Director of Research and Clinical Trials at TriCore Reference Laboratory will present performance comparisons of the Accula visually read PCR testing platform with other FDA-cleared molecular tests for influenza A/B and respiratory syncytial virus (RSV) assays. The lecture will take place on August 6, 2019 at 1:00 pm in theater 3 of the exhibit hall at AACC.
Medical device OEMs in search of commercialization and manufacturing solutions for lateral flow immunoassay (LFI) and medical diagnostic devices will discover several new capabilities and services that virtually eliminate product variability, improve overall quality and lower costs from contract manufacturer (CMO) Web Industries at AACC 2019, August 4 – 8, Anaheim Convention Center.
At AACC, Festo introduces a 96-head bulk dispenser which will be used for speeding up sample handling. Festo continues to innovate in the liquid dispensing and automated sample handling arena.
Decades ago, automation changed the face of laboratory testing forever. However, the methods to manage the people staffing the laboratory have changed little. StaffReady's Clinical Workforce Management Software automates laboratory staff management.
Mesa Biotech Inc., a privately-held, molecular diagnostic company that has developed an affordable, sample-to-answer, CLIA-waived PCR (polymerase chain reaction) testing platform designed specifically for point-of-care (POC) infectious disease diagnosis, today announced the launch of its respiratory syncytial virus test (RSV). Mesa will demonstrate its expanded, novel Accula™ Test System at the 71st American Association of Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo. The Accula System's RSV and Flu A/Flu B molecular tests will be on exhibit in Booth 3902. Sekisui Diagnostics distributes both products in the US under the Silaris™ brand.
Randox Laboratories has this month announced its achievement in being awarded the Manufacturer Certification by the National Glycohemoglobin Standardization Program (NGSP); for direct HbA1c testing on three of its clinical chemistry analysers; the RX modena, RX imola and RX daytona+.
MARLBOROUGH, Mass. – July 25, 2019 – Medical device OEMs in search of commercialization and manufacturing solutions for lateral flow immunization (LFI) and medical diagnostic devices will discover several new capabilities and services that virtually eliminate product variability, improve overall quality and lower costs from contract manufacturer (CMO) Web Industries at AACC 2019, August 4 – 8, Anaheim Convention Center.
Streck will showcase three new antibiotic resistance detection kits and the new RNA Complete BCT™ at the 71st AACC Annual Scientific Meeting & Clinical Lab Expo held Aug. 6-8 at the Anaheim Convention Center. Streck will be at Booth 2035.
STRATEC takes a further step towards the diversification of its product portfolio by introducing stand-alone modules and a new chemiluminescence immunoassay platform as adjuncts to its core business- the development and manufacturing of OEM instrumentation.
ELITechGroup, recognized worldwide for proven performance and reliability of clinical laboratory instruments and currently nominated for SelectScience’s Best New Clinical Instrumentation of 2018, is pleased the announce the release of FreezePoint™ Freezing Point Osmometer.
Pixcell’s HemoScreen™ is a portable cartridge driven platform. It is fast, simple to use, and a cost-effective means of providing crucial diagnostic information, near patient, where it is needed most.
Global diagnostics company Randox Laboratories has unveiled an innovative new test for the risk assessment of cardiovascular disease at this year’s AACC Clinical Lab Expo in Anaheim, California.